Literature DB >> 21069427

Recurrence in childhood medulloblastoma.

Monika Warmuth-Metz1, Sophia Blashofer, André O von Bueren, Katja von Hoff, Brigitte Bison, Fabian Pohl, Rolf-Dieter Kortmann, Torsten Pietsch, Stefan Rutkowski.   

Abstract

Thirty-eight consecutive children treated according to the HIT2000 and HIT91 studies for medulloblastoma who suffered 40 recurrence events were identified from a neuroradiological database. Relapse was associated with younger median age compared with all children treated on HIT2000. Eight patients relapsed with isolated local recurrence. There was no correlation with incomplete surgical removal or violation of the respective treatment protocol. Four patients were younger than 4 years at time of initial presentation and thus were not treated primarily with radiotherapy, suggesting that delayed radiotherapy might be a contributing factor. Meningeal dissemination was present in 32 events; 16 were located in the frontal region, 8 of which were isolated nodular frontal and frontobasal meningeal disease. Circumscribed meningeal recurrences were associated with better overall survival (OS) compared with diffuse, widespread recurrences. Isolated frontobasal meningeal relapses are a well-known phenomenon in medulloblastomas even years after treatment and have been correlated to an underdose of radiation in many literature reports. However, in our patients there was no correlation to possible treatment violations, indicating that inadequate radiation dose to the frontobasal region was unlikely to be a causative factor. Surgical technique varied due to the multicentric nature of our study, so position during surgery was not recognized as a predisposing factor for frontobasal recurrence.

Entities:  

Mesh:

Year:  2010        PMID: 21069427     DOI: 10.1007/s11060-010-0452-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.

Authors:  Li-Min Sun; Shyh-An Yeh; Chong-Jong Wang; Eng-Yen Huang; Hui-Chun Chen; Hsuan-Chih Hsu; Steve P Lee
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

2.  Population-based epidemiologic data on brain tumors in German children.

Authors:  P Kaatsch; C H Rickert; J Kühl; J Schüz; J Michaelis
Journal:  Cancer       Date:  2001-12-15       Impact factor: 6.860

Review 3.  Impact of radiation technique upon the outcome of treatment for medulloblastoma.

Authors:  E C Halperin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-08-01       Impact factor: 7.038

4.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

5.  Ocular globe topography in radiotherapy.

Authors:  U Karlsson; T Kirby; W Orrison; M Lionberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-10-15       Impact factor: 7.038

6.  Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.

Authors:  U Sure; H Bertalanffy; S Isenmann; S Brandner; W J Berghorn; W Seeger; A Aguzzi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

8.  Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.

Authors:  Roger E Taylor; Clifford C Bailey; Kathryn J Robinson; Claire L Weston; David Ellison; James Ironside; Helen Lucraft; Richard Gilbertson; Diana M Tait; Frank Saran; David A Walker; Barry L Pizer; Linda S Lashford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-15       Impact factor: 7.038

9.  Patterns of failure in surgical therapy of medulloblastomas.

Authors:  C Di Rocco; A Iannelli; A Tancredi
Journal:  J Neurosurg Sci       Date:  1995-03       Impact factor: 2.279

10.  Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

Authors:  E Bouffet; F Doz; M C Demaille; P Tron; H Roche; D Plantaz; A Thyss; J L Stephan; O Lejars; E Sariban; M Buclon; J M Zücker; M Brunat-Mentigny; J L Bernard; J C Gentet
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more
  11 in total

Review 1.  Subfrontal recurrence after cerebellar medulloblastoma resection without local relapse: case-based update.

Authors:  He Yue; Wang Ling; Ou Yibo; Wang Sheng; Tang Sicheng; Chen Jincao; Guo Dongsheng
Journal:  Childs Nerv Syst       Date:  2018-06-23       Impact factor: 1.475

Review 2.  The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature.

Authors:  M Balducci; S Chiesa; D Chieffo; S Manfrida; N Dinapoli; A Fiorentino; F Miccichè; V Frascino; C Anile; V Valentini; B De Bari
Journal:  J Neurooncol       Date:  2011-07-31       Impact factor: 4.130

3.  Evidence of high mortality in long term survivors of childhood medulloblastoma.

Authors:  Matthew S Ning; Stephanie M Perkins; Todd Dewees; Eric T Shinohara
Journal:  J Neurooncol       Date:  2015-01-04       Impact factor: 4.130

4.  Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.

Authors:  Franz L Ricklefs; Friederike Fritzsche; Beate Winkler; Barbara Meissner; Lasse Dührsen; Manfred Westphal; Stefan Rutkowski; Tobias Martens; Ulrich Schüller
Journal:  Childs Nerv Syst       Date:  2019-02-22       Impact factor: 1.475

5.  Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.

Authors:  N Patrik Brodin; Per Munck af Rosenschöld; Malin Blomstrand; Anne Kiil-Berthlesen; Christian Hollensen; Ivan R Vogelius; Birgitta Lannering; Søren M Bentzen; Thomas Björk-Eriksson
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

6.  Relapse patterns in pediatric embryonal central nervous system tumors.

Authors:  Sébastien Perreault; Robert M Lober; Anne-Sophie Carret; Guohua Zhang; Linda Hershon; Jean-Claude Décarie; Kristen Yeom; Hannes Vogel; Paul G Fisher; Sonia Partap
Journal:  J Neurooncol       Date:  2013-08-07       Impact factor: 4.130

7.  Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.

Authors:  Vijay Ramaswamy; Marc Remke; Eric Bouffet; Claudia C Faria; Sebastien Perreault; Yoon-Jae Cho; David J Shih; Betty Luu; Adrian M Dubuc; Paul A Northcott; Ulrich Schüller; Sridharan Gururangan; Roger McLendon; Darell Bigner; Maryam Fouladi; Keith L Ligon; Scott L Pomeroy; Sandra Dunn; Joanna Triscott; Nada Jabado; Adam Fontebasso; David T W Jones; Marcel Kool; Matthias A Karajannis; Sharon L Gardner; David Zagzag; Sofia Nunes; José Pimentel; Jaume Mora; Eric Lipp; Andrew W Walter; Marina Ryzhova; Olga Zheludkova; Ella Kumirova; Jad Alshami; Sidney E Croul; James T Rutka; Cynthia Hawkins; Uri Tabori; Kari-Elise T Codispoti; Roger J Packer; Stefan M Pfister; Andrey Korshunov; Michael D Taylor
Journal:  Lancet Oncol       Date:  2013-10-17       Impact factor: 41.316

Review 8.  Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors.

Authors:  Jenny Adamski; Vijay Ramaswamy; Annie Huang; Eric Bouffet
Journal:  F1000Prime Rep       Date:  2014-07-08

9.  Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model.

Authors:  Ji Hoon Phi; Seung Ah Choi; Pil Ae Kwak; Ji Yeoun Lee; Kyu-Chang Wang; Do Won Hwang; Seung-Ki Kim
Journal:  Oncotarget       Date:  2017-05-24

10.  Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.

Authors:  Giovanni Morana; Cesar Augusto Alves; Domenico Tortora; Mariasavina Severino; Paolo Nozza; Armando Cama; Marcello Ravegnani; Gabriella D'Apolito; Alessandro Raso; Claudia Milanaccio; Claudia da Costa Leite; Maria Luisa Garrè; Andrea Rossi
Journal:  Oncotarget       Date:  2017-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.